Marcin Frąckiewicz

Amazon stock slips again as AI spending anxiety lingers; Nvidia’s Feb. 25 report looms

Amazon stock slips again as AI spending anxiety lingers; Nvidia’s Feb. 25 report looms

Amazon shares fell 0.9% to $196.98 Tuesday morning amid concerns over its $200 billion AI infrastructure spending plan for 2026. Investors questioned whether heavy capex would deliver returns, especially after Amazon forecast first-quarter operating income below Wall Street estimates. The S&P 500 and Nasdaq also opened lower as traders tracked U.S.-Iran nuclear talks.
February 17, 2026
Sandisk stock slides as AI jitters hit chip names again — what’s next for SNDK

Sandisk stock slides as AI jitters hit chip names again — what’s next for SNDK

Sandisk shares fell 3.5% to $604.75 Tuesday, hitting a low of $593.82 as memory stocks slid after the holiday. The drop followed broader market losses tied to AI disruption concerns and caution ahead of Federal Reserve minutes. Western Digital, Micron, and Seagate also declined. Sandisk, spun off from Western Digital last year, has surged recently on strong earnings and AI-driven demand.
February 17, 2026
Accenture stock price: what to watch for ACN as Wall Street reopens after Presidents Day

Accenture stock price: what to watch for ACN as Wall Street reopens after Presidents Day

Accenture shares last closed at $224.23, up 0.9%, ahead of a U.S. market pause for Presidents Day. Investors are watching for signs that AI spending will keep supporting tech valuations, with Accenture’s next earnings call set for March 19. The company reported strong AI demand in December but noted uneven public sector business. About 7.6 million shares traded Friday, with a range between $220.63 and $227.08.
February 17, 2026
Bank of America stock price holds near $52 as BAC heads into Tuesday reopen with Fed minutes, inflation data ahead

Bank of America stock price holds near $52 as BAC heads into Tuesday reopen with Fed minutes, inflation data ahead

Bank of America closed at $52.55, down one cent, in Friday’s session before U.S. markets paused for Presidents Day. Trading resumes Tuesday, with investors awaiting Fed minutes Wednesday and GDP and inflation data Friday. Market watchers expect these releases to influence rate-cut bets and bank share moves. U.S. stock and bond markets were shut Monday.
February 17, 2026
Adobe stock price in focus as ADBE nears Tuesday reopen after Presidents Day

Adobe stock price in focus as ADBE nears Tuesday reopen after Presidents Day

Adobe shares closed up 0.5% at $263.97 Friday, just above their 52-week low, ahead of a trading pause for Presidents Day. The stock is down 25% in 2026 as investors question the impact of AI on subscription pricing and await the $1.9 billion Semrush acquisition. U.S. markets reopen Tuesday, with traders watching for further selling or a rebound. Adobe’s next earnings report is due March 12.
February 17, 2026
IBM stock price faces post-holiday test after FlashSystem buzz and AI hiring push

IBM stock price faces post-holiday test after FlashSystem buzz and AI hiring push

IBM shares closed Friday up 1.1% at $262.38 after steep declines earlier in the week left the stock about 10% below its Feb. 10 close. U.S. markets reopen Tuesday after Presidents Day, with traders eyeing key economic data and Federal Reserve minutes. IBM drew attention for plans to triple U.S. entry-level hiring and for new FlashSystem storage products shipping March 6.
February 17, 2026
T-Mobile stock (TMUS) at $219: buybacks, euro notes and dividend date in focus

T-Mobile stock (TMUS) at $219: buybacks, euro notes and dividend date in focus

T-Mobile US shares closed at $219.50, up 2.3%, ahead of the Presidents Day market holiday. The company projects 2026 service revenue of $77 billion and plans to double Q1 share repurchases to $5 billion. T-Mobile will stop reporting postpaid phone subscriber additions, shifting focus to account growth and ARPA. It agreed to sell €2.5 billion in senior notes, with proceeds possibly used for buybacks or dividends.
February 17, 2026
Qualcomm stock price: QCOM heads into Tuesday reopen with memory crunch in focus

Qualcomm stock price: QCOM heads into Tuesday reopen with memory crunch in focus

QUALCOMM shares closed up 1.6% at $140.70 on Friday ahead of the U.S. market closure for Washington’s Birthday. The stock faces its next test Tuesday as traders watch for memory-chip supply updates and upcoming Fed minutes. Qualcomm continues to warn on memory shortages, forecasting Q2 revenue below analyst estimates. Mobile World Congress in Barcelona opens March 2.
February 17, 2026
Nebius (NBIS) stock heads into Tuesday test after 9% jump and holiday pause

Nebius (NBIS) stock heads into Tuesday test after 9% jump and holiday pause

Nebius shares closed at $98.01 Friday, up 9.23%, after reporting Q4 revenue of $227.7 million, missing estimates, and a net loss of $249.6 million. Capital expenditures jumped to $2.1 billion from $416 million a year earlier. The company ended 2025 with $3.7 billion in cash and posted its first quarter of positive operating cash flow. U.S. markets were closed Monday for Presidents Day.
February 17, 2026
Uber stock price: $1 billion Uber Eats Europe expansion puts UBER in focus before Tuesday open

Uber stock price: $1 billion Uber Eats Europe expansion puts UBER in focus before Tuesday open

Uber will expand food delivery into seven European countries in 2026, aiming for $1 billion in added gross bookings over three years. Shares closed Friday down 1.73% at $69.99. The move follows Uber’s $335 million deal to buy Getir’s food delivery business in Türkiye. CFO Prashanth Mahendra-Rajah stepped down Friday, with Balaji Krishnamurthy taking over.
February 17, 2026
AbbVie stock: ABBV heads into Tuesday restart after $231.50 close as Botox pricing fight lingers

AbbVie stock: ABBV heads into Tuesday restart after $231.50 close as Botox pricing fight lingers

AbbVie shares closed Friday at $231.50, up 1.76%, before U.S. markets paused for Presidents Day. Investors await Tuesday’s reopening, with focus on AbbVie’s court fight to keep Botox out of Medicare price negotiations and a raised dividend. Trading volume outpaced recent averages Friday. The company faces ongoing pressure from biosimilar competition and weaker-than-expected Rinvoq sales.
February 17, 2026
1 146 147 148 149 150 168